Understanding Cannabis in Psychiatry: Pharmacology and Synthetic Cannabinoids
December 7, 2018 DOI: 10.64239/pi-vl00605 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Topics | Cannabis |
|---|---|
| Key points | Cardiovascular symptoms can help identify synthetic cannabinoid toxicity. |
Abstract
The endocannabinoid system consists of: CB1 and CB2 receptors Endogenous ligands such as anandamide, 2‐arachidonoylglycerol (2-AG) Synthetic cannabinoids are CB1 full agonists, their effect is even stronger than Sinsemilla The presence of cardiovascular symptoms can help identify synthetic cannabinoid toxicity